Key result
Mean glycated albumin levels were associated with the progression of diabetic nephropathy in subjects with type 1 diabetes, whereas mean HbA1c was not.
Why the study?
Do glycated albumin levels predict the progression of diabetic nephropathy and carotid artery atherosclerosis better than HbA1c in subjects with type 1 diabetes?
Cohort (n=154)
No
Do glycated albumin levels predict the progression of diabetic nephropathy and carotid artery atherosclerosis better than HbA1c in subjects with type 1 diabetes?
In subjects with type 1 diabetes, mean glycated albumin levels are a better predictor of diabetic nephropathy progression than HbA1c, though neither predicts carotid atherosclerosis progression.
Answers are grounded in this paper and cite their sources.
Glycated albumin may aid nephropathy risk stratification in type 1 diabetes; leaves open whether it should replace HbA1c monitoring.
BACKGROUND: We investigated the relationship between the glycemic indices glycated albumin (GA) and glycated hemoglobin (HbA1c) and the progression of diabetic vascular complications [diabetic nephropathy (DN) and carotid artery atherosclerosis (CAA)] in subjects with type 1 diabetes (T1D). METHODS: A total of 154 participants with a median follow-up of 2.8 years were enrolled in this retrospective longitudinal study. We recruited T1D subjects who had regularly measured urine albumin-creatinine ratios and estimated glomerular filtration rates, as well as tested HbA1c and GA levels consecutively every 3 or 6 months. A subgroup of 54 subjects was measured repeated carotid intima-media thickness (IMT). RESULTS: We classified subjects into the DN progression (Group I; n = 30) with either deteriorated stages of chronic kidney disease (n = 18) or albuminuria progression (n = 17), and the non-progression (Group II; n = 124). In multiple logistic regression analyses, baseline albuminuria (odds ratio [OR] = 2.64, 95 % confidence interval [CI] = 1.03-6.74), mean GA levels (OR = 2.03, 95 % CI = 1.27-3.26) were significantly associated with progression of DN. However, there was no association with mean HbA1c (OR = 0.98, 95 % CI = 0.62-1.54). In a subgroup analysis for follow-up measurements of carotid IMT, age was independently associated with the presence of plaque and the mean IMT. However glycemic indices were not significantly associated with CAA. CONCLUSIONS: Mean GA levels were more closely associated with DN progression than mean HbA1c in subjects with T1D. However, they were not associated with the CAA.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2015) conducted a cohort in Type 1 Diabetes (n=154). Mean glycated albumin (GA) levels vs. Mean HbA1c levels was evaluated on Progression of diabetic nephropathy (OR 2.03, 95% CI 1.27-3.26, p=0.003). Mean glycated albumin levels were associated with the progression of diabetic nephropathy in subjects with type 1 diabetes, whereas mean HbA1c was not.
Synapse has enriched 10 related papers. Consider them for comparative context: